Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Numerous cancer drugs have received accelerated approval from the US Food and Drug Administration (FDA) based on clinical trial outcomes that are otherwise not acceptable for traditional FDA approval; the accelerated approval process allows outcomes based on surrogate measures that are only reasonab...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JAMA internal medicine Jg. 181; H. 4; S. 490
Hauptverfasser:	Cherla, Avi, Naci, Huseyin, Kesselheim, Aaron S, Gyawali, Bishal, Mossialos, Elias
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.04.2021
Schlagworte:	Antineoplastic Agents - economics Cohort Studies Drug Approval Humans Insurance Coverage State Medicine
ISSN:	2168-6114, 2168-6114
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!